Two Sigma Advisers
LPCN icon

Two Sigma Advisers’s Lipocine LPCN Stock Holding History

Two Sigma Advisers’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,822
Closed -$106K – 2413
2024
Q2 		$106K Sell
12,822
-12,900
-50% -$80.7K ﹤0.01% 2316
2024
Q1 		$134K Sell
25,722
-500
-2% -$1.95K ﹤0.01% 2280
2023
Q4 		$73.2K Sell
26,222
-30,700
-54% -$81.2K ﹤0.01% 2361
2023
Q3 		$170K Buy
+56,922
New +$239K ﹤0.01% 2128
2023
Q2 		– Sell
-7,765
Closed -$42K – 2544
2023
Q1 		$42K Sell
7,765
-1,794
-19% -$13.9K ﹤0.01% 2466
2022
Q4 		$64.6K Sell
9,559
-2,770
-22% -$20.2K ﹤0.01% 2341
2022
Q3 		$94K Sell
12,329
-5,883
-32% -$65.7K ﹤0.01% 2315
2022
Q2 		$248K Buy
18,212
+9,836
+117% +$153K ﹤0.01% 2190
2022
Q1 		$195K Buy
8,376
+5,258
+169% +$110K ﹤0.01% 2389
2021
Q4 		$53K Buy
+3,118
New +$57.9K ﹤0.01% 2469
2021
Q2 		– Sell
-1,524
Closed -$39K – 2581
2021
Q1 		$39K Buy
+1,524
New +$44K ﹤0.01% 2508
2020
Q4 		– Sell
-888
Closed -$21K – 2498
2020
Q3 		$21K Sell
888
-200
-18% -$5.31K ﹤0.01% 2359
2020
Q2 		$23K Buy
+1,088
New +$14.1K ﹤0.01% 2457

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's LPCN Position: Q3 2024 in Review

Two Sigma Advisers sold out of Lipocine (LPCN) in Q3 2024, closing a stake of 12,822 shares — an estimated $106K sold.

Two Sigma Advisers first reported a position in LPCN in Q2 2020 and held it in 13 quarters. The position peaked at $248K in Q2 2022. 18 funds tracked by Wall St. Rank hold LPCN as of Q3 2024.

  • Two Sigma Advisers reported no remaining Lipocine position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 12,822 Lipocine shares in Q3 2024, an estimated $106K.
  • Two Sigma Advisers first reported a position in Lipocine in Q2 2020 and held it in 13 quarters.
  • Two Sigma Advisers's Lipocine position peaked at $248K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Lipocine as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.